Menopause Pipeline Highlights – 2017 – Research and Markets

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Menopause
Pipeline Highlights – 2017”
drug pipelines to their offering.

This report, Menopause Pipeline Highlights – 2017, provides most
up-to-date information on key pipeline products in the global Menopause
market. It covers emerging therapies for Menopause in active clinical
development stages including early and late stage clinical trials. The
pipeline data presented in this report helps executives for tracking
competition, identifying partners, evaluating opportunities, formulating
business development strategies, and executing in-licensing and
out-licensing deals.

Clinical Trial Stages:

The report provides Menopause pipeline products by clinical trial stages
including both early and late stage development – phase 3 clinical
trials, phase 2 clinical trials, phase 1 clinical trials, preclinical
research, and discovery stage.

Drug Mechanism Classes:

The report provides Menopause pipeline products by their dominant
mechanism of action. This helps executives categorize products based on
their drug class and also assess the strengths and weaknesses of


The report provides Menopause pipeline products by the company.

Short-term Launch Highlights:

Find out which Menopause pipeline products will be launched in the US
and Ex-US till 2020.


  • Menopause phase 3 clinical trial pipeline products
  • Menopause phase 2 clinical trial pipeline products
  • Menopause phase 1 clinical trial pipeline products
  • Menopause preclinical research pipeline products
  • Menopause discovery stage pipeline products
  • Menopause pipeline products short-term launch highlights

Key Topics Covered:

1. Menopause Pipeline by Stages

2. Menopause Pipeline by Drug Class

3. Menopause Pipeline by Company

4. Menopause Phase 3 Clinical Trial Insights

5. Menopause Phase 2 Clinical Trial Insights

6. Menopause Phase 1 Clinical Trial Insights

7. Menopause Preclinical Research Insights

8. Menopause Discovery Stage Insights

9. Appendix

10. Research Methodology

For more information about this drug pipelines report visit


Research and Markets
Laura Wood, Senior Manager
E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Topics: Women’s
, Sexual
and Reproductive Health Drugs